Biocidal Advantage EOScu is an EPA-registered hard surface material that continuously and actively kills bacteria, including after recontamination, offering a compelling differentiator for high-touch environments seeking enhanced infection control.

Healthcare Relevance Independent peer-reviewed studies and clinical trials show reductions in infection rates and bioburden, positioning EOScu as a credible solution for hospitals, clinics, long-term care, and other healthcare facilities aiming to improve patient safety metrics.

Rapid Deployment The material can be thermoformed or injection molded and installed on bedrails, overbed tables, countertops, and vanities within days, enabling swift upgrades to existing facilities and accelerated time-to-value.

Expansion Readiness EOS Surfaces’ flexible fabrication capabilities and broad surface portfolio align with contractors and facilities looking to retrofit or specify biocidal surfaces across new builds and renovations.

Strategic Outreach Key selling points include infection prevention impact, MDRO and C. difficile reductions, and the ability to integrate with existing facility procurement processes leveraging partners, distributors, and Bio-safety program stakeholders.